Literature DB >> 11062760

Effects of citrus phytochemicals on liver and lung cytochrome P450 activity and on the in vitro metabolism of the tobacco-specific nitrosamine NNK.

W L Bear1, R W Teel.   

Abstract

NNK is a potent environmental carcinogen to which both smokers and nonsmokers are exposed. The response to NNK may be affected by factors including nutrition. We investigated the effects of five citrus phytochemicals on the in vitro metabolism of the tobacco-specific nitrosamine NNK and on the dealkylation of methoxyresorufin (MROD) and pentoxyresorufin (PROD) in liver and lung microsomes of the Syrian golden hamster. In the NNK metabolism experiments in vitro incubations contained 3 microCi [5-H3] NNK, 0.5 mg microsomal protein and 0.5 mumole of the citrus phytochemical diosmin, naringin, naringenin, quercetin or rutin. In the dealkylation studies incubations contained 0.5 microM methoxyresorufin or pentoxyresorufin, 0.5 mg microsomal protein and 0.5 mumole of citrus phytochemical. The major NNK metabolism pathway in hamster liver microsomes was NNK-reduction while in lung microsomes it was alpha-hydroxylation. The alpha-hydroxylation pathway produces metabolic products that methylate and pyridyloxobutylate DNA. Naringenin, a metabolite of naringin, and quercetin were the most potent inhibitors of alpha-hydroxylation of NNK in both liver and lung microsomes. This inhibition correlated with a potent inhibition of MROD and PROD activity in liver but not in lung microsomes. The metabolic activation of NNK is associated with cytochrome P450 isoforms 1A1, 1A2, 2B1, 2D6 and 2E1. Our results suggest that naringenin and quercetin from citrus fruits inhibit the activity of cytochrome P450 (CYP) isoforms that activate NNK and may afford protection against NNK-induced carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062760

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms.

Authors:  Wenjie Jessie Lu; Valentina Ferlito; Cong Xu; David Alastair Flockhart; Salvatore Caccamese
Journal:  Chirality       Date:  2011-09-22       Impact factor: 2.437

2.  Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats.

Authors:  Satish Kumar Bedada; Prasad Neerati
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-11-14       Impact factor: 3.000

3.  Diosmin pretreatment affects bioavailability of metronidazole.

Authors:  K Rajnarayana; Mada S Reddy; Devarakonda R Krishna
Journal:  Eur J Clin Pharmacol       Date:  2003-03-01       Impact factor: 2.953

4.  Hepatoprotective evaluation of Anogeissus latifolia: in vitro and in vivo studies.

Authors:  Hulikere Ananth Pradeep; Saleemullah Khan; Karamkonda Ravikumar; Mohammed Fazil Ahmed; Meesala Srinivasa Rao; Mandava Kiranmai; Dachani Sudhershan Reddy; Shaik Rasheed Ahamed; Mohammed Ibrahim
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

5.  Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics.

Authors:  Rao Mukkavilli; Sushma R Gundala; Chunhua Yang; Shashikiran Donthamsetty; Guilherme Cantuaria; Gajanan R Jadhav; Subrahmanyam Vangala; Michelle D Reid; Ritu Aneja
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

Review 6.  [Research progress of lung cancer on single nuleotide polymorphism].

Authors:  Feng Hua; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-02

7.  Current update on the protective effect of naringin in inflammatory lung diseases.

Authors:  Gaurav Gupta; Waleed Hassan Almalki; Imran Kazmi; Neeraj Kumar Fuloria; Shivkanya Fuloria; Vetriselvan Subramaniyan; Mahendran Sekar; Sachin Kumar Singh; Dinesh Kumar Chellappan; Kamal Dua
Journal:  EXCLI J       Date:  2022-03-07       Impact factor: 4.022

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.